This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
902 pLNCX myr HA Akt1 K179M
catalog :
9006
citations: 3
| Reference |
|---|
Wasson C, Morgan E, Müller M, Ross R, Hartley M, Roberts S, et al. Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle. Oncotarget. 2017;8:103581-103600 pubmed publisher
|
Ramaswamy S, Nakamura N, Vazquez F, Batt D, Perera S, Roberts T, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A. 1999;96:2110-5 pubmed
|
product information
Catalog Number :
9006
Product Name :
902 pLNCX myr HA Akt1 K179M
article :
| doi | 10.1073/pnas.96.5.2110 |
| id | 351 |
| pubmed_id | 10051603 |
bacterial resistance :
Ampicillin
cloning :
| backbone | pLNCX | ||
| backbone_mutation | |||
| backbone_origin | BD Biosciences | ||
| backbone_size | 6600 | ||
| promoter | |||
| sequencing_primer_3 | |||
| sequencing_primer_5 | |||
| vector_types |
|
growth notes :
An Akt-1 cDNA was amplified by reverse transcription-coupled PCR from total HeLa cell RNA and reamplified with a 5' primer containing a Kozak sequence and sequences encoding a hemagglutinin (HA) epitope and cloned into pLNCX to give pLNCX-HA-Akt. A double-stranded oligonucleotide encoding the src myristoylation sequence was inserted 5' of the HA tag to generate pLNCX-Myr-HA-Akt. K179M mutation generated using site-directed mutagenesis.
origin :
37
pi :
|
resistance markers :
| 455 |
tags :
High Copy
terms :
| Neomycin (select with G418) |
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
Watertown, MA 02472
info@addgene.org
https://www.addgene.org617.225.9000
headquarters: USA
questions and comments
